Our Sites » TechNews TechDatabase Canadian Private Equity &nsbp;

LoginSubscribe DatabaseScreen Shots


Akela Pharm Announces Layoffs, Restructuring and Management Changes

TechFinance.ca News
Thursday September 3, 2009

Akela Pharma, Inc. (TSX: AKL) along with its wholly owned manufacturing subsidiary, PharmaForm, today announced a c...



[ ... to read the whole article, please Log IN or Subscribe ... ]



... ... to optimize the infrastructure required to support its PharmaForm clients. Several of Akela's international opera...


To read this or any other article, or trial test our database, please try our 7 days or 1 month subscription, Click Here for Details.





Company Deals and People
Date
Title
Type
2010/12/16
Director
2009/9/3
Rudy Emmelot, VP, Finance
Management
2009/9/3
Marcelo Omelczuk, SVP, Business and Product Development
Management
2009/9/2
Gregory M. McKee, President & CEO
Management
2009/6/25
Director
2009/6/25
Director
2009/5/22
Akela Pharma Closes Acquisition of Nventa Biopharmaceuticals
M&A
2009/5/22
Director
2008/6/26
Director
2008/3/27
Akela Pharma Completes Short Form Prospectus Offering
Financing
2007/10/15
AKELA Pharma Announces US Public Offering - Abandoned 12/20/2007
Financing
2007/3/3
Ed Margerrison, VP, Programme Management
Management
2007/1/26
Director
2007/1/25
LAB International Completes Acquisition of PharmaForm LLC
M&A
2007/1/11
Roman Denk, VP, Corporate Support
Management
2005/12/13
LAB International Closes $12.3 Million Financing
Financing
2005/4/27
LAB International Closes US $5 Million Financing
Financing
2005/2/10
LAB International Acquires Scantox
M&A
2005/1/18
Luc Mainville, COO
Management
2005/1/18
Andrew Reiter, CFO, COO
Management
2005/1/18
LAB International Raises Additional $2.4 Million
Financing
2005/1/18
Hanns-Christian Palka, VP, Risk Management and Controller
Management
2004/12/30
LAB International Closes Private Placement
Financing
2004/8/26
Denis Pilon, COO of LAB Research's Canadian Operation
Management
2004/6/9
Taneli Jouhikainen, SVP, Corporate Development & acting CEO
Management
2004/1/12
LAB International Closes €4 Million Financing
Financing
2003/12/22
LAB International Completes Financing
Financing
2003/10/2
Yves Cornellier, SVP, Business Development
Management
2003/9/24
Ron Kaczorowski, President & COO
Management
2002/12/20
LAB International Closes Financing
Financing
2002/3/5
LAB International/1467523 Ontario Completes Financing
Financing

 
Akela Pharma Inc.
TSX: AKL; Frankfurt: LD9.F; XETRA: LD9.DE
formerly: LAB International Inc.
» To this firm page « (subscriber only)

3333 Côte Vertu, Suite 710
St-Laurent, QC   H4R 2N1
Tel:  (450) 315-3330
Fax:  (450) 315-3325
http://www.akelapharma.com

Sector - Biotechnology, Biopharmaceuticals

Business Description
Akela Pharma is a developer of therapeutics for the treatment of pain, and its PharmaForm subsidiary provides a range of innovative technologies in drug product development, manufacturing and analytical testing to the pharmaceutical and biotechnology industries.


Company News
Akela Pharm Announces Layoffs, Restructuring and Management Changes 2009/9/3
Akela Pharma Announces New Board of Directors 2009/6/26
Akela and Nventa Complete Merger 2009/5/22
LAB International Completes $12.3 Million PIPE Financing 2005/12/13
LAB International Acquires Danish CRO Scantox 2005/2/10